

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of histone H3-K27 methylation (GO:0061085) | 8.32583702 |
| 2 | interferon-gamma production (GO:0032609) | 6.79784941 |
| 3 | presynaptic membrane assembly (GO:0097105) | 6.52800305 |
| 4 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 6.20214350 |
| 5 | postsynaptic membrane organization (GO:0001941) | 6.12561778 |
| 6 | mature B cell differentiation (GO:0002335) | 5.71712009 |
| 7 | Golgi to endosome transport (GO:0006895) | 5.60569905 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.28743637 |
| 9 | COPI coating of Golgi vesicle (GO:0048205) | 4.97222295 |
| 10 | Golgi transport vesicle coating (GO:0048200) | 4.97222295 |
| 11 | presynaptic membrane organization (GO:0097090) | 4.95817363 |
| 12 | regulation of metalloenzyme activity (GO:0048552) | 4.90402010 |
| 13 | mannose metabolic process (GO:0006013) | 4.78500555 |
| 14 | protein heterotetramerization (GO:0051290) | 4.63757610 |
| 15 | generation of neurons (GO:0048699) | 4.38659934 |
| 16 | regulation of stem cell maintenance (GO:2000036) | 4.32400491 |
| 17 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.07953891 |
| 18 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.07953891 |
| 19 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.00343411 |
| 20 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.99173390 |
| 21 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.97989232 |
| 22 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.97989232 |
| 23 | omega-hydroxylase P450 pathway (GO:0097267) | 3.94527147 |
| 24 | cellular response to exogenous dsRNA (GO:0071360) | 3.78953236 |
| 25 | negative T cell selection (GO:0043383) | 3.69888175 |
| 26 | protein localization to endosome (GO:0036010) | 3.68523527 |
| 27 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.66432271 |
| 28 | regulation of gamma-delta T cell activation (GO:0046643) | 3.63109419 |
| 29 | viral transcription (GO:0019083) | 3.61240633 |
| 30 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.60798067 |
| 31 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.58388013 |
| 32 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.58388013 |
| 33 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.58041093 |
| 34 | positive thymic T cell selection (GO:0045059) | 3.57084002 |
| 35 | response to folic acid (GO:0051593) | 3.56286235 |
| 36 | positive T cell selection (GO:0043368) | 3.49629563 |
| 37 | barbed-end actin filament capping (GO:0051016) | 3.47124817 |
| 38 | negative thymic T cell selection (GO:0045060) | 3.44643299 |
| 39 | regulation of response to tumor cell (GO:0002834) | 3.44178926 |
| 40 | positive regulation of response to tumor cell (GO:0002836) | 3.44178926 |
| 41 | positive regulation of immune response to tumor cell (GO:0002839) | 3.44178926 |
| 42 | regulation of immune response to tumor cell (GO:0002837) | 3.44178926 |
| 43 | negative regulation of cell size (GO:0045792) | 3.41871739 |
| 44 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.39159426 |
| 45 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.30709443 |
| 46 | negative regulation of cell killing (GO:0031342) | 3.30709443 |
| 47 | translational termination (GO:0006415) | 3.25173242 |
| 48 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.24548745 |
| 49 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.23958585 |
| 50 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.23208570 |
| 51 | negative regulation of phagocytosis (GO:0050765) | 3.22483604 |
| 52 | thymic T cell selection (GO:0045061) | 3.20652585 |
| 53 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.19587369 |
| 54 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.16907156 |
| 55 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.16689159 |
| 56 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.15920665 |
| 57 | positive regulation of osteoclast differentiation (GO:0045672) | 3.14683155 |
| 58 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 3.12011899 |
| 59 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.08636641 |
| 60 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.07426740 |
| 61 | regulation of ruffle assembly (GO:1900027) | 3.06854793 |
| 62 | stress fiber assembly (GO:0043149) | 3.06046220 |
| 63 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.04880772 |
| 64 | T cell selection (GO:0045058) | 3.04006590 |
| 65 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.02918653 |
| 66 | negative regulation of type 2 immune response (GO:0002829) | 3.02337220 |
| 67 | mature B cell differentiation involved in immune response (GO:0002313) | 3.01390046 |
| 68 | protein targeting to ER (GO:0045047) | 3.01389918 |
| 69 | melanin metabolic process (GO:0006582) | 2.96731675 |
| 70 | cotranslational protein targeting to membrane (GO:0006613) | 2.96213481 |
| 71 | mast cell activation (GO:0045576) | 2.95677174 |
| 72 | response to laminar fluid shear stress (GO:0034616) | 2.94021631 |
| 73 | NIK/NF-kappaB signaling (GO:0038061) | 2.94010187 |
| 74 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.93886409 |
| 75 | anterior/posterior axis specification, embryo (GO:0008595) | 2.91565993 |
| 76 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 2.91547594 |
| 77 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.90336086 |
| 78 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.90336086 |
| 79 | cellular defense response (GO:0006968) | 2.88816276 |
| 80 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.88705440 |
| 81 | adherens junction assembly (GO:0034333) | 2.88554451 |
| 82 | positive regulation of cell killing (GO:0031343) | 2.87535009 |
| 83 | pinocytosis (GO:0006907) | 2.86855440 |
| 84 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.86073730 |
| 85 | protein localization to endoplasmic reticulum (GO:0070972) | 2.85824195 |
| 86 | cell-substrate adherens junction assembly (GO:0007045) | 2.85378177 |
| 87 | focal adhesion assembly (GO:0048041) | 2.85378177 |
| 88 | amyloid precursor protein catabolic process (GO:0042987) | 2.84654382 |
| 89 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.84630320 |
| 90 | activation of Rac GTPase activity (GO:0032863) | 2.84107062 |
| 91 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.83456050 |
| 92 | ribosomal small subunit biogenesis (GO:0042274) | 2.82387619 |
| 93 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.81992106 |
| 94 | protein retention in ER lumen (GO:0006621) | 2.81923175 |
| 95 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.81152415 |
| 96 | cellular extravasation (GO:0045123) | 2.80995614 |
| 97 | dendritic cell chemotaxis (GO:0002407) | 2.80387470 |
| 98 | adult heart development (GO:0007512) | 2.80116481 |
| 99 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.80019002 |
| 100 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.77082898 |
| 101 | facial nerve structural organization (GO:0021612) | 2.77002189 |
| 102 | modulation by symbiont of host cellular process (GO:0044068) | 2.76973802 |
| 103 | positive regulation of humoral immune response (GO:0002922) | 2.75232841 |
| 104 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.72158872 |
| 105 | negative regulation of metanephros development (GO:0072217) | 2.72111222 |
| 106 | response to peptidoglycan (GO:0032494) | 2.72083559 |
| 107 | myeloid dendritic cell activation (GO:0001773) | 2.72007576 |
| 108 | cellular modified amino acid catabolic process (GO:0042219) | 2.71816369 |
| 109 | regulation of cell killing (GO:0031341) | 2.71436452 |
| 110 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.69447901 |
| 111 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.68709620 |
| 112 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.68428425 |
| 113 | hepatocyte apoptotic process (GO:0097284) | 2.66876595 |
| 114 | positive regulation by symbiont of host defense response (GO:0052509) | 2.66709179 |
| 115 | modulation by symbiont of host defense response (GO:0052031) | 2.66709179 |
| 116 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.66709179 |
| 117 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.66709179 |
| 118 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.66709179 |
| 119 | modulation by symbiont of host immune response (GO:0052553) | 2.66709179 |
| 120 | negative regulation of inclusion body assembly (GO:0090084) | 2.65837699 |
| 121 | positive regulation of defense response to virus by host (GO:0002230) | 2.63940686 |
| 122 | pentose-phosphate shunt (GO:0006098) | 2.63685854 |
| 123 | regulation of defense response to virus by virus (GO:0050690) | 2.61500661 |
| 124 | radial glial cell differentiation (GO:0060019) | 2.61160733 |
| 125 | modulation by virus of host process (GO:0019054) | 2.60966764 |
| 126 | ribosomal small subunit assembly (GO:0000028) | 2.60767637 |
| 127 | membrane assembly (GO:0071709) | 2.60583286 |
| 128 | vesicle targeting (GO:0006903) | 2.59873873 |
| 129 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.56365145 |
| 130 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.56322519 |
| 131 | positive regulation of receptor recycling (GO:0001921) | 2.55623897 |
| 132 | detection of other organism (GO:0098543) | 2.55556119 |
| 133 | positive regulation of nuclease activity (GO:0032075) | 2.54496474 |
| 134 | serine family amino acid catabolic process (GO:0009071) | 2.54113136 |
| 135 | retrograde transport, endosome to Golgi (GO:0042147) | 2.54004807 |
| 136 | definitive hemopoiesis (GO:0060216) | 2.53680241 |
| 137 | positive regulation of B cell differentiation (GO:0045579) | 2.53628069 |
| 138 | response to muramyl dipeptide (GO:0032495) | 2.52967624 |
| 139 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.52905328 |
| 140 | detection of bacterium (GO:0016045) | 2.52668065 |
| 141 | regulation of B cell differentiation (GO:0045577) | 2.52083944 |
| 142 | negative regulation of viral release from host cell (GO:1902187) | 2.50933370 |
| 143 | embryonic process involved in female pregnancy (GO:0060136) | 2.48148002 |
| 144 | regulation of early endosome to late endosome transport (GO:2000641) | 2.48113000 |
| 145 | regulation of leukocyte degranulation (GO:0043300) | 2.46271915 |
| 146 | negative regulation of necroptotic process (GO:0060546) | 2.44312838 |
| 147 | regulation of ARF protein signal transduction (GO:0032012) | 2.43987757 |
| 148 | vesicle coating (GO:0006901) | 2.43176924 |
| 149 | regulation of extracellular matrix disassembly (GO:0010715) | 2.42395501 |
| 150 | skin morphogenesis (GO:0043589) | 2.42301953 |
| 151 | regulation of necrotic cell death (GO:0010939) | 2.42162065 |
| 152 | cell-substrate junction assembly (GO:0007044) | 2.41647923 |
| 153 | cellular response to virus (GO:0098586) | 2.41597635 |
| 154 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.38306839 |
| 155 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.38068303 |
| 156 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.37270269 |
| 157 | negative regulation of necrotic cell death (GO:0060547) | 2.36655593 |
| 158 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.36304862 |
| 159 | amyloid precursor protein metabolic process (GO:0042982) | 2.35010352 |
| 160 | activation of JUN kinase activity (GO:0007257) | 2.34942672 |
| 161 | regulation of necroptotic process (GO:0060544) | 2.34942656 |
| 162 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.34915447 |
| 163 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.34722263 |
| 164 | basement membrane organization (GO:0071711) | 2.34492332 |
| 165 | maternal placenta development (GO:0001893) | 2.33535669 |
| 166 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.33009573 |
| 167 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.32587535 |
| 168 | positive regulation of protein dephosphorylation (GO:0035307) | 2.29972828 |
| 169 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.29751401 |
| 170 | regulation of nuclease activity (GO:0032069) | 2.27607468 |
| 171 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.27317887 |
| 172 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.27125148 |
| 173 | macrophage activation involved in immune response (GO:0002281) | 2.26269301 |
| 174 | leukocyte aggregation (GO:0070486) | 2.26115446 |
| 175 | histone H3-K36 demethylation (GO:0070544) | 2.25646382 |
| 176 | response to host (GO:0075136) | 2.25254207 |
| 177 | response to host defenses (GO:0052200) | 2.25254207 |
| 178 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.25254207 |
| 179 | regulation of macrophage cytokine production (GO:0010935) | 2.24788044 |
| 180 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.24582094 |
| 181 | germinal center formation (GO:0002467) | 2.24227109 |
| 182 | ER-nucleus signaling pathway (GO:0006984) | 2.21859383 |
| 183 | modulation by virus of host morphology or physiology (GO:0019048) | 2.21439803 |
| 184 | negative regulation of skeletal muscle tissue development (GO:0048642) | 2.20144237 |
| 185 | response to type I interferon (GO:0034340) | 2.19577756 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.03762639 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.73906244 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.38382345 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.62405425 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.36870191 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.32177764 |
| 7 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.08704434 |
| 8 | * MAF_26560356_Chip-Seq_TH1_Human | 2.97090162 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.87799626 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.84594677 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.82713592 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.80407007 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.80188095 |
| 14 | MYB_26560356_Chip-Seq_TH2_Human | 2.74582157 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 2.72601771 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.57370147 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.52948765 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.52190440 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.50786240 |
| 20 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.48555325 |
| 21 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.47713289 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.41719068 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.37933652 |
| 24 | MYB_26560356_Chip-Seq_TH1_Human | 2.33262999 |
| 25 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.29752087 |
| 26 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.28486487 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.28361716 |
| 28 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 2.22986492 |
| 29 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.19180957 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 2.19033039 |
| 31 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.18504386 |
| 32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.01294127 |
| 33 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.00699675 |
| 34 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93133757 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.92558053 |
| 36 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.90426961 |
| 37 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.89550796 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.89123885 |
| 39 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.89103608 |
| 40 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.88875570 |
| 41 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.88637108 |
| 42 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.87433321 |
| 43 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.87284226 |
| 44 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.87187541 |
| 45 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.85033374 |
| 46 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.83135349 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.81002440 |
| 48 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.79304297 |
| 49 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.76850019 |
| 50 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.75621499 |
| 51 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.74983675 |
| 52 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.71325825 |
| 53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69922274 |
| 54 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.69574133 |
| 55 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.68889843 |
| 56 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.67755248 |
| 57 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.66370405 |
| 58 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.60783795 |
| 59 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.57959085 |
| 60 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.55771571 |
| 61 | KDM2B_26808549_Chip-Seq_K562_Human | 1.55177060 |
| 62 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.50682187 |
| 63 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.50452396 |
| 64 | * MAF_26560356_Chip-Seq_TH2_Human | 1.49496394 |
| 65 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.49083340 |
| 66 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.48343417 |
| 67 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.48130355 |
| 68 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.47881009 |
| 69 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.46848162 |
| 70 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.46503075 |
| 71 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.46077181 |
| 72 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.45730766 |
| 73 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.44822324 |
| 74 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.44456023 |
| 75 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.44332834 |
| 76 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.43905578 |
| 77 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42568517 |
| 78 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.42075051 |
| 79 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.39828805 |
| 80 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.39415784 |
| 81 | SPI1_23127762_ChIP-Seq_K562_Human | 1.38643819 |
| 82 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.37910896 |
| 83 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.36388137 |
| 84 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.36019286 |
| 85 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.35109729 |
| 86 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.35030269 |
| 87 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.33944481 |
| 88 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.33552112 |
| 89 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.33225799 |
| 90 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.32906190 |
| 91 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.32568434 |
| 92 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32430754 |
| 93 | P68_20966046_ChIP-Seq_HELA_Human | 1.32234744 |
| 94 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.31408492 |
| 95 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.31307971 |
| 96 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.31160939 |
| 97 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.30689966 |
| 98 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.30474761 |
| 99 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.27889181 |
| 100 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.27712795 |
| 101 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.26475793 |
| 102 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.24876935 |
| 103 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24205452 |
| 104 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21984771 |
| 105 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.21855509 |
| 106 | GATA2_19941826_ChIP-Seq_K562_Human | 1.21431709 |
| 107 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.21024607 |
| 108 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.20482808 |
| 109 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.20139919 |
| 110 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.19530112 |
| 111 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.18862262 |
| 112 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18394149 |
| 113 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.18377773 |
| 114 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.18236669 |
| 115 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.18213004 |
| 116 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.18121300 |
| 117 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.17210004 |
| 118 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.17125350 |
| 119 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.16755364 |
| 120 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.14620500 |
| 121 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.14362852 |
| 122 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13396296 |
| 123 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.13135342 |
| 124 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.12381497 |
| 125 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10571617 |
| 126 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.10142288 |
| 127 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.09599332 |
| 128 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.08914864 |
| 129 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.08843392 |
| 130 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08352615 |
| 131 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.07596320 |
| 132 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07366218 |
| 133 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.07262303 |
| 134 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.07218160 |
| 135 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06381464 |
| 136 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.06113386 |
| 137 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.04481441 |
| 138 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.04200859 |
| 139 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.03973072 |
| 140 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.03707970 |
| 141 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03668049 |
| 142 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.01994931 |
| 143 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01718606 |
| 144 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.01523047 |
| 145 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.01458734 |
| 146 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.01017070 |
| 147 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00502501 |
| 148 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.99913994 |
| 149 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99769808 |
| 150 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99346407 |
| 151 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.96934082 |
| 152 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.95576347 |
| 153 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.92901293 |
| 154 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92335506 |
| 155 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91777225 |
| 156 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90862422 |
| 157 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.88283931 |
| 158 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.88150867 |
| 159 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83226707 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 4.03718882 |
| 2 | MP0002009_preneoplasia | 3.48477763 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 3.33020515 |
| 4 | MP0005451_abnormal_body_composition | 3.16993168 |
| 5 | MP0004381_abnormal_hair_follicle | 2.86430188 |
| 6 | MP0002166_altered_tumor_susceptibility | 2.85284125 |
| 7 | MP0009840_abnormal_foam_cell | 2.81000896 |
| 8 | MP0003880_abnormal_central_pattern | 2.80737614 |
| 9 | MP0006292_abnormal_olfactory_placode | 2.80539141 |
| 10 | MP0003763_abnormal_thymus_physiology | 2.75267327 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 2.74950605 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.60057109 |
| 13 | MP0005174_abnormal_tail_pigmentation | 2.59389079 |
| 14 | MP0005671_abnormal_response_to | 2.55939023 |
| 15 | MP0005409_darkened_coat_color | 2.43602575 |
| 16 | MP0003172_abnormal_lysosome_physiology | 2.42458187 |
| 17 | MP0000685_abnormal_immune_system | 2.37212189 |
| 18 | MP0003436_decreased_susceptibility_to | 2.27453679 |
| 19 | MP0001790_abnormal_immune_system | 2.26134393 |
| 20 | MP0005387_immune_system_phenotype | 2.26134393 |
| 21 | MP0003136_yellow_coat_color | 2.25534519 |
| 22 | MP0001800_abnormal_humoral_immune | 2.24196451 |
| 23 | MP0008438_abnormal_cutaneous_collagen | 2.23446127 |
| 24 | MP0003868_abnormal_feces_composition | 2.23014537 |
| 25 | MP0000015_abnormal_ear_pigmentation | 2.21803565 |
| 26 | MP0002006_tumorigenesis | 2.21625668 |
| 27 | MP0009278_abnormal_bone_marrow | 2.20097758 |
| 28 | MP0005076_abnormal_cell_differentiation | 2.18376298 |
| 29 | MP0009785_altered_susceptibility_to | 2.14170608 |
| 30 | MP0005000_abnormal_immune_tolerance | 2.11310051 |
| 31 | MP0002452_abnormal_antigen_presenting | 1.99735898 |
| 32 | MP0005025_abnormal_response_to | 1.97960216 |
| 33 | MP0003566_abnormal_cell_adhesion | 1.96526216 |
| 34 | MP0002420_abnormal_adaptive_immunity | 1.96176235 |
| 35 | MP0002723_abnormal_immune_serum | 1.95626725 |
| 36 | MP0001819_abnormal_immune_cell | 1.94555188 |
| 37 | MP0003724_increased_susceptibility_to | 1.93550432 |
| 38 | MP0003091_abnormal_cell_migration | 1.91125639 |
| 39 | MP0001188_hyperpigmentation | 1.82561592 |
| 40 | MP0002419_abnormal_innate_immunity | 1.75630658 |
| 41 | MP0005075_abnormal_melanosome_morpholog | 1.74983988 |
| 42 | MP0004947_skin_inflammation | 1.73966206 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.73844251 |
| 44 | MP0003303_peritoneal_inflammation | 1.69452210 |
| 45 | MP0003866_abnormal_defecation | 1.68773738 |
| 46 | MP0005464_abnormal_platelet_physiology | 1.67633625 |
| 47 | MP0002148_abnormal_hypersensitivity_rea | 1.66900316 |
| 48 | MP0003453_abnormal_keratinocyte_physiol | 1.66144928 |
| 49 | MP0000681_abnormal_thyroid_gland | 1.65396754 |
| 50 | MP0000858_altered_metastatic_potential | 1.63114276 |
| 51 | MP0002398_abnormal_bone_marrow | 1.62979035 |
| 52 | MP0001958_emphysema | 1.62422314 |
| 53 | MP0004233_abnormal_muscle_weight | 1.61806825 |
| 54 | MP0001849_ear_inflammation | 1.61750582 |
| 55 | MP0003656_abnormal_erythrocyte_physiolo | 1.60974131 |
| 56 | MP0003329_amyloid_beta_deposits | 1.55521719 |
| 57 | MP0000716_abnormal_immune_system | 1.53773938 |
| 58 | MP0004185_abnormal_adipocyte_glucose | 1.51772725 |
| 59 | MP0000372_irregular_coat_pigmentation | 1.51387322 |
| 60 | MP0002095_abnormal_skin_pigmentation | 1.43757264 |
| 61 | MP0008007_abnormal_cellular_replicative | 1.42286105 |
| 62 | MP0002138_abnormal_hepatobiliary_system | 1.41687234 |
| 63 | MP0003300_gastrointestinal_ulcer | 1.41156960 |
| 64 | MP0004858_abnormal_nervous_system | 1.39647374 |
| 65 | MP0005670_abnormal_white_adipose | 1.39277134 |
| 66 | MP0010155_abnormal_intestine_physiology | 1.31257640 |
| 67 | MP0009333_abnormal_splenocyte_physiolog | 1.30709437 |
| 68 | MP0001845_abnormal_inflammatory_respons | 1.28945814 |
| 69 | MP0004808_abnormal_hematopoietic_stem | 1.27922646 |
| 70 | MP0010234_abnormal_vibrissa_follicle | 1.27152759 |
| 71 | MP0000689_abnormal_spleen_morphology | 1.26519149 |
| 72 | MP0002876_abnormal_thyroid_physiology | 1.26090098 |
| 73 | MP0000751_myopathy | 1.24677125 |
| 74 | MP0002429_abnormal_blood_cell | 1.24583205 |
| 75 | MP0000490_abnormal_crypts_of | 1.23473048 |
| 76 | MP0006082_CNS_inflammation | 1.23171219 |
| 77 | MP0003828_pulmonary_edema | 1.22005029 |
| 78 | MP0000733_abnormal_muscle_development | 1.20983446 |
| 79 | MP0001545_abnormal_hematopoietic_system | 1.20568911 |
| 80 | MP0002722_abnormal_immune_system | 1.19351257 |
| 81 | MP0008469_abnormal_protein_level | 1.19257000 |
| 82 | MP0003279_aneurysm | 1.18694268 |
| 83 | MP0003690_abnormal_glial_cell | 1.17935108 |
| 84 | MP0004510_myositis | 1.17312069 |
| 85 | MP0005058_abnormal_lysosome_morphology | 1.17239138 |
| 86 | MP0005621_abnormal_cell_physiology | 1.15875616 |
| 87 | MP0000703_abnormal_thymus_morphology | 1.14439619 |
| 88 | MP0002796_impaired_skin_barrier | 1.14058888 |
| 89 | MP0000604_amyloidosis | 1.13437255 |
| 90 | MP0003448_altered_tumor_morphology | 1.12336509 |
| 91 | MP0005666_abnormal_adipose_tissue | 1.12145515 |
| 92 | MP0002177_abnormal_outer_ear | 1.09569792 |
| 93 | MP0009764_decreased_sensitivity_to | 1.07081954 |
| 94 | MP0005375_adipose_tissue_phenotype | 1.06643677 |
| 95 | MP0005084_abnormal_gallbladder_morpholo | 1.06106427 |
| 96 | MP0002998_abnormal_bone_remodeling | 1.05424640 |
| 97 | MP0002060_abnormal_skin_morphology | 1.04311467 |
| 98 | MP0000003_abnormal_adipose_tissue | 1.04279440 |
| 99 | MP0008260_abnormal_autophagy | 1.03175606 |
| 100 | MP0005023_abnormal_wound_healing | 1.01753373 |
| 101 | MP0000767_abnormal_smooth_muscle | 1.01113324 |
| 102 | MP0003075_altered_response_to | 1.00149954 |
| 103 | MP0000678_abnormal_parathyroid_gland | 0.99913055 |
| 104 | MP0003943_abnormal_hepatobiliary_system | 0.99741509 |
| 105 | MP0003221_abnormal_cardiomyocyte_apopto | 0.97931448 |
| 106 | MP0000371_diluted_coat_color | 0.97508202 |
| 107 | MP0005257_abnormal_intraocular_pressure | 0.95297968 |
| 108 | MP0002405_respiratory_system_inflammati | 0.95177726 |
| 109 | MP0004264_abnormal_extraembryonic_tissu | 0.92450868 |
| 110 | MP0001853_heart_inflammation | 0.92357151 |
| 111 | MP0005501_abnormal_skin_physiology | 0.91814080 |
| 112 | MP0003183_abnormal_peptide_metabolism | 0.91569683 |
| 113 | MP0001944_abnormal_pancreas_morphology | 0.90895836 |
| 114 | MP0000759_abnormal_skeletal_muscle | 0.90840145 |
| 115 | MP0003252_abnormal_bile_duct | 0.90748075 |
| 116 | MP0008874_decreased_physiological_sensi | 0.90644574 |
| 117 | MP0002877_abnormal_melanocyte_morpholog | 0.90298836 |
| 118 | MP0003011_delayed_dark_adaptation | 0.89012540 |
| 119 | MP0001533_abnormal_skeleton_physiology | 0.88343311 |
| 120 | MP0002396_abnormal_hematopoietic_system | 0.87504413 |
| 121 | MP0001851_eye_inflammation | 0.85818087 |
| 122 | MP0000747_muscle_weakness | 0.85644310 |
| 123 | MP0005360_urolithiasis | 0.84464819 |
| 124 | MP0005408_hypopigmentation | 0.83321603 |
| 125 | MP0002693_abnormal_pancreas_physiology | 0.82843600 |
| 126 | MP0009931_abnormal_skin_appearance | 0.82830103 |
| 127 | MP0005390_skeleton_phenotype | 0.82741870 |
| 128 | MP0003191_abnormal_cellular_cholesterol | 0.81831768 |
| 129 | MP0008961_abnormal_basal_metabolism | 0.79755395 |
| 130 | MP0001765_abnormal_ion_homeostasis | 0.79077695 |
| 131 | MP0005636_abnormal_mineral_homeostasis | 0.78097671 |
| 132 | MP0002638_abnormal_pupillary_reflex | 0.77071503 |
| 133 | MP0000343_altered_response_to | 0.76943631 |
| 134 | MP0002928_abnormal_bile_duct | 0.76567082 |
| 135 | MP0002933_joint_inflammation | 0.76317141 |
| 136 | MP0003634_abnormal_glial_cell | 0.76037361 |
| 137 | MP0003795_abnormal_bone_structure | 0.75969881 |
| 138 | MP0001873_stomach_inflammation | 0.75306134 |
| 139 | MP0005166_decreased_susceptibility_to | 0.74788020 |
| 140 | MP0000609_abnormal_liver_physiology | 0.74313767 |
| 141 | MP0002075_abnormal_coat/hair_pigmentati | 0.73110191 |
| 142 | MP0009763_increased_sensitivity_to | 0.70723573 |
| 143 | MP0006054_spinal_hemorrhage | 0.68683304 |
| 144 | MP0005365_abnormal_bile_salt | 0.68011755 |
| 145 | MP0010329_abnormal_lipoprotein_level | 0.66615897 |
| 146 | MP0001186_pigmentation_phenotype | 0.66040913 |
| 147 | MP0001348_abnormal_lacrimal_gland | 0.65437019 |
| 148 | MP0005085_abnormal_gallbladder_physiolo | 0.64988914 |
| 149 | MP0005248_abnormal_Harderian_gland | 0.64595612 |
| 150 | MP0005397_hematopoietic_system_phenotyp | 0.64426459 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pseudobulbar signs (HP:0002200) | 5.23240911 |
| 2 | Decreased circulating renin level (HP:0003351) | 4.64857644 |
| 3 | Hyperactive renin-angiotensin system (HP:0000841) | 4.49165478 |
| 4 | Abnormal hemoglobin (HP:0011902) | 4.28197600 |
| 5 | Reduced antithrombin III activity (HP:0001976) | 3.97899947 |
| 6 | Abnormality of renin-angiotensin system (HP:0000847) | 3.92946512 |
| 7 | Glomerulonephritis (HP:0000099) | 3.88151897 |
| 8 | Hyponatremia (HP:0002902) | 3.78742448 |
| 9 | Amelogenesis imperfecta (HP:0000705) | 3.49062795 |
| 10 | Stomatitis (HP:0010280) | 3.47859407 |
| 11 | Meningitis (HP:0001287) | 3.47512482 |
| 12 | Vertebral compression fractures (HP:0002953) | 3.45793315 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.38809127 |
| 14 | Cone-rod dystrophy (HP:0000548) | 3.36815064 |
| 15 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.33937153 |
| 16 | Vacuolated lymphocytes (HP:0001922) | 3.26451638 |
| 17 | Type I transferrin isoform profile (HP:0003642) | 3.21939763 |
| 18 | Metabolic alkalosis (HP:0200114) | 3.19987790 |
| 19 | Agammaglobulinemia (HP:0004432) | 3.12107496 |
| 20 | Abnormality of chloride homeostasis (HP:0011422) | 3.05083140 |
| 21 | Abnormality of dental color (HP:0011073) | 3.00406891 |
| 22 | Nonprogressive disorder (HP:0003680) | 3.00044424 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 2.99616986 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.99616986 |
| 25 | Intellectual disability, progressive (HP:0006887) | 2.98290340 |
| 26 | Abnormality of sodium homeostasis (HP:0010931) | 2.93167770 |
| 27 | Joint hemorrhage (HP:0005261) | 2.91457474 |
| 28 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.91373589 |
| 29 | Spontaneous hematomas (HP:0007420) | 2.90286265 |
| 30 | Dysostosis multiplex (HP:0000943) | 2.84600267 |
| 31 | Hyperacusis (HP:0010780) | 2.84242739 |
| 32 | Obstructive sleep apnea (HP:0002870) | 2.83724703 |
| 33 | Broad face (HP:0000283) | 2.76743283 |
| 34 | Thyroid-stimulating hormone excess (HP:0002925) | 2.76434921 |
| 35 | Microcytic anemia (HP:0001935) | 2.73780041 |
| 36 | Distal lower limb muscle weakness (HP:0009053) | 2.73763437 |
| 37 | Protrusio acetabuli (HP:0003179) | 2.73065594 |
| 38 | Increased connective tissue (HP:0009025) | 2.68670771 |
| 39 | Alkalosis (HP:0001948) | 2.66540935 |
| 40 | Premature rupture of membranes (HP:0001788) | 2.65938141 |
| 41 | Mediastinal lymphadenopathy (HP:0100721) | 2.65473259 |
| 42 | Recurrent fungal infections (HP:0002841) | 2.63795761 |
| 43 | Distal lower limb amyotrophy (HP:0008944) | 2.62662932 |
| 44 | Hyperglycinemia (HP:0002154) | 2.62594737 |
| 45 | Abnormality of T cell number (HP:0011839) | 2.60605841 |
| 46 | Cervical subluxation (HP:0003308) | 2.58001137 |
| 47 | Gastrointestinal infarctions (HP:0005244) | 2.55191377 |
| 48 | T lymphocytopenia (HP:0005403) | 2.53151988 |
| 49 | Eczematoid dermatitis (HP:0000976) | 2.51631136 |
| 50 | Chronic obstructive pulmonary disease (HP:0006510) | 2.51507371 |
| 51 | Obstructive lung disease (HP:0006536) | 2.51507371 |
| 52 | Lower limb hyperreflexia (HP:0002395) | 2.48717702 |
| 53 | Recurrent abscess formation (HP:0002722) | 2.47710407 |
| 54 | Thoracic kyphosis (HP:0002942) | 2.45755283 |
| 55 | Upper limb amyotrophy (HP:0009129) | 2.45290659 |
| 56 | Distal upper limb amyotrophy (HP:0007149) | 2.45290659 |
| 57 | Loss of speech (HP:0002371) | 2.45155888 |
| 58 | Cerebral aneurysm (HP:0004944) | 2.42483516 |
| 59 | Epistaxis (HP:0000421) | 2.41467909 |
| 60 | Prolonged partial thromboplastin time (HP:0003645) | 2.40997555 |
| 61 | Hypothermia (HP:0002045) | 2.40171977 |
| 62 | Abnormality of glycolipid metabolism (HP:0010969) | 2.39692801 |
| 63 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.39692801 |
| 64 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.39692801 |
| 65 | Abnormality of T cells (HP:0002843) | 2.36617868 |
| 66 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.35597458 |
| 67 | Gingival bleeding (HP:0000225) | 2.34684006 |
| 68 | Abnormality of macrophages (HP:0004311) | 2.33594889 |
| 69 | Myositis (HP:0100614) | 2.33536216 |
| 70 | Neuronal loss in central nervous system (HP:0002529) | 2.33090631 |
| 71 | Nephritis (HP:0000123) | 2.32905522 |
| 72 | Hemoptysis (HP:0002105) | 2.32576075 |
| 73 | Recurrent skin infections (HP:0001581) | 2.31547354 |
| 74 | Recurrent viral infections (HP:0004429) | 2.31439269 |
| 75 | Macrocytic anemia (HP:0001972) | 2.25688404 |
| 76 | Late onset (HP:0003584) | 2.24833516 |
| 77 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.24406967 |
| 78 | Mucopolysacchariduria (HP:0008155) | 2.24406967 |
| 79 | J-shaped sella turcica (HP:0002680) | 2.24313051 |
| 80 | Panhypogammaglobulinemia (HP:0003139) | 2.23674376 |
| 81 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.22897938 |
| 82 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.22897938 |
| 83 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.22897938 |
| 84 | Autoimmune thrombocytopenia (HP:0001973) | 2.22666058 |
| 85 | Recurrent bacterial skin infections (HP:0005406) | 2.21862975 |
| 86 | Vasculitis (HP:0002633) | 2.21151799 |
| 87 | Abnormality of T cell physiology (HP:0011840) | 2.19989855 |
| 88 | Increased variability in muscle fiber diameter (HP:0003557) | 2.19412172 |
| 89 | Thin bony cortex (HP:0002753) | 2.18955952 |
| 90 | Achilles tendon contracture (HP:0001771) | 2.17137279 |
| 91 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.16973932 |
| 92 | IgG deficiency (HP:0004315) | 2.15344963 |
| 93 | Increased IgM level (HP:0003496) | 2.13917406 |
| 94 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.13818177 |
| 95 | Colitis (HP:0002583) | 2.13723499 |
| 96 | Hyperglycinuria (HP:0003108) | 2.13699390 |
| 97 | Neonatal onset (HP:0003623) | 2.13591709 |
| 98 | Syringomyelia (HP:0003396) | 2.13237004 |
| 99 | Spinal cord lesions (HP:0100561) | 2.13237004 |
| 100 | Inflammation of the large intestine (HP:0002037) | 2.13152295 |
| 101 | Abnormal protein glycosylation (HP:0012346) | 2.12492338 |
| 102 | Abnormal glycosylation (HP:0012345) | 2.12492338 |
| 103 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.12492338 |
| 104 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.12492338 |
| 105 | Hyperaldosteronism (HP:0000859) | 2.12242615 |
| 106 | IgM deficiency (HP:0002850) | 2.11134872 |
| 107 | Excessive salivation (HP:0003781) | 2.11003320 |
| 108 | Drooling (HP:0002307) | 2.11003320 |
| 109 | Encephalitis (HP:0002383) | 2.09747638 |
| 110 | Testicular atrophy (HP:0000029) | 2.08571827 |
| 111 | Dilatation of the ascending aorta (HP:0005111) | 2.07727029 |
| 112 | Cholecystitis (HP:0001082) | 2.07627683 |
| 113 | Abnormal gallbladder physiology (HP:0012438) | 2.07627683 |
| 114 | Cellulitis (HP:0100658) | 2.05898515 |
| 115 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.05709401 |
| 116 | Cerebral inclusion bodies (HP:0100314) | 2.05666458 |
| 117 | Fatigue (HP:0012378) | 2.02819836 |
| 118 | Hand muscle atrophy (HP:0009130) | 2.02040305 |
| 119 | Gastrointestinal stroma tumor (HP:0100723) | 2.01711029 |
| 120 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.01433347 |
| 121 | Spinal rigidity (HP:0003306) | 2.01398519 |
| 122 | Supranuclear gaze palsy (HP:0000605) | 2.01326576 |
| 123 | Abnormality of the prostate (HP:0008775) | 2.01138254 |
| 124 | Prolonged bleeding time (HP:0003010) | 2.00215106 |
| 125 | Thrombocytosis (HP:0001894) | 1.99621006 |
| 126 | Flat acetabular roof (HP:0003180) | 1.99305358 |
| 127 | Increased cerebral lipofuscin (HP:0011813) | 1.99233047 |
| 128 | Cheilitis (HP:0100825) | 1.99047380 |
| 129 | Leiomyosarcoma (HP:0100243) | 1.97315990 |
| 130 | Uterine leiomyosarcoma (HP:0002891) | 1.97315990 |
| 131 | Gastrointestinal inflammation (HP:0004386) | 1.97090206 |
| 132 | Adrenal overactivity (HP:0002717) | 1.94389808 |
| 133 | Hyperparathyroidism (HP:0000843) | 1.92785408 |
| 134 | Stridor (HP:0010307) | 1.92591110 |
| 135 | Increased IgE level (HP:0003212) | 1.92530708 |
| 136 | Abdominal distention (HP:0003270) | 1.92438223 |
| 137 | Interstitial pulmonary disease (HP:0006530) | 1.92395616 |
| 138 | Eosinophilia (HP:0001880) | 1.91457773 |
| 139 | Skin rash (HP:0000988) | 1.91057229 |
| 140 | Chest pain (HP:0100749) | 1.91026592 |
| 141 | Complement deficiency (HP:0004431) | 1.90818981 |
| 142 | Basal ganglia calcification (HP:0002135) | 1.90818507 |
| 143 | Growth hormone excess (HP:0000845) | 1.90382153 |
| 144 | Reticulocytopenia (HP:0001896) | 1.90340042 |
| 145 | Biconcave vertebral bodies (HP:0004586) | 1.89739176 |
| 146 | Neurofibrillary tangles (HP:0002185) | 1.89498511 |
| 147 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.89392026 |
| 148 | Axonal loss (HP:0003447) | 1.88934281 |
| 149 | Hypercortisolism (HP:0001578) | 1.88678980 |
| 150 | Hypertensive crisis (HP:0100735) | 1.88161736 |
| 151 | Aneurysm (HP:0002617) | 1.88059207 |
| 152 | Abnormal drinking behavior (HP:0030082) | 1.87946759 |
| 153 | Polydipsia (HP:0001959) | 1.87946759 |
| 154 | Ulnar bowing (HP:0003031) | 1.87067682 |
| 155 | Slow saccadic eye movements (HP:0000514) | 1.86614894 |
| 156 | Osteolytic defects of the hand bones (HP:0009699) | 1.85856913 |
| 157 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.85856913 |
| 158 | Hemorrhage of the eye (HP:0011885) | 1.85501561 |
| 159 | Abnormality of the Achilles tendon (HP:0005109) | 1.85406231 |
| 160 | Mitral regurgitation (HP:0001653) | 1.81689900 |
| 161 | Seborrheic dermatitis (HP:0001051) | 1.81044277 |
| 162 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.80507453 |
| 163 | Insomnia (HP:0100785) | 1.80283367 |
| 164 | Emphysema (HP:0002097) | 1.79472807 |
| 165 | Exercise-induced myalgia (HP:0003738) | 1.78089412 |
| 166 | Sparse lateral eyebrow (HP:0005338) | 1.77424246 |
| 167 | Reticulocytosis (HP:0001923) | 1.76438028 |
| 168 | Foot dorsiflexor weakness (HP:0009027) | 1.75465907 |
| 169 | Abnormality of the thoracic spine (HP:0100711) | 1.73919797 |
| 170 | Lower limb amyotrophy (HP:0007210) | 1.72481416 |
| 171 | Gingivitis (HP:0000230) | 1.72268889 |
| 172 | Asymmetric septal hypertrophy (HP:0001670) | 1.72177672 |
| 173 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.71084136 |
| 174 | Long toe (HP:0010511) | 1.70254868 |
| 175 | Spondylolisthesis (HP:0003302) | 1.69907291 |
| 176 | Peripheral hypomyelination (HP:0007182) | 1.69069638 |
| 177 | Distal sensory impairment (HP:0002936) | 1.66197488 |
| 178 | Hammertoe (HP:0001765) | 1.64842880 |
| 179 | Blue sclerae (HP:0000592) | 1.64170536 |
| 180 | Ragged-red muscle fibers (HP:0003200) | 1.63971726 |
| 181 | Wormian bones (HP:0002645) | 1.63925800 |
| 182 | Long palpebral fissure (HP:0000637) | 1.63154803 |
| 183 | Gastrointestinal dysmotility (HP:0002579) | 1.62282051 |
| 184 | Bone pain (HP:0002653) | 1.62159340 |
| 185 | Short nail (HP:0001799) | 1.61972105 |
| 186 | Generalized amyotrophy (HP:0003700) | 1.61012738 |
| 187 | Disproportionate tall stature (HP:0001519) | 1.60784313 |
| 188 | Amyloidosis (HP:0011034) | 1.59957148 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NLK | 3.74226824 |
| 2 | TLK1 | 3.48962138 |
| 3 | CLK1 | 3.41109467 |
| 4 | TSSK6 | 3.38358887 |
| 5 | IRAK3 | 3.05736303 |
| 6 | IRAK4 | 2.94865803 |
| 7 | TXK | 2.73351956 |
| 8 | CASK | 2.63599328 |
| 9 | MAP4K1 | 2.61792944 |
| 10 | TNIK | 2.46904865 |
| 11 | SMG1 | 2.46876416 |
| 12 | NME2 | 2.32618974 |
| 13 | HIPK2 | 2.29103944 |
| 14 | ICK | 2.20189173 |
| 15 | TGFBR2 | 2.16720401 |
| 16 | GRK6 | 2.13731244 |
| 17 | MAPK15 | 2.07249362 |
| 18 | EIF2AK3 | 1.98404754 |
| 19 | CDK12 | 1.90580291 |
| 20 | RIPK1 | 1.90172822 |
| 21 | STK11 | 1.87780510 |
| 22 | MAP3K14 | 1.82817417 |
| 23 | TAOK3 | 1.81366108 |
| 24 | SIK3 | 1.71375152 |
| 25 | IKBKE | 1.70650011 |
| 26 | EEF2K | 1.69432548 |
| 27 | TAOK2 | 1.68742226 |
| 28 | TAOK1 | 1.67625578 |
| 29 | TESK1 | 1.65532268 |
| 30 | TEC | 1.65481263 |
| 31 | MAP3K3 | 1.63292938 |
| 32 | IRAK1 | 1.61376574 |
| 33 | BTK | 1.58901639 |
| 34 | JAK3 | 1.53658671 |
| 35 | IRAK2 | 1.52124233 |
| 36 | PKN2 | 1.51084823 |
| 37 | ZAP70 | 1.48739996 |
| 38 | YES1 | 1.42859324 |
| 39 | TBK1 | 1.42089791 |
| 40 | KSR2 | 1.39910331 |
| 41 | CSK | 1.38971910 |
| 42 | TTN | 1.36048297 |
| 43 | MKNK2 | 1.32227954 |
| 44 | PIM1 | 1.29035718 |
| 45 | MST4 | 1.28977049 |
| 46 | PDGFRA | 1.27920695 |
| 47 | NEK9 | 1.26098217 |
| 48 | EPHA2 | 1.25670357 |
| 49 | SCYL2 | 1.24299347 |
| 50 | IKBKB | 1.23670986 |
| 51 | EIF2AK1 | 1.23335788 |
| 52 | MARK2 | 1.22078040 |
| 53 | EPHA3 | 1.20970314 |
| 54 | KIT | 1.19614486 |
| 55 | UHMK1 | 1.17436098 |
| 56 | MUSK | 1.16916719 |
| 57 | MAP3K11 | 1.16867613 |
| 58 | MAP3K6 | 1.10848961 |
| 59 | DYRK1B | 1.09198535 |
| 60 | PAK4 | 1.09187348 |
| 61 | FGR | 1.07594472 |
| 62 | FGFR3 | 1.07034334 |
| 63 | JAK1 | 1.05877938 |
| 64 | FES | 1.04154148 |
| 65 | FGFR4 | 1.02331858 |
| 66 | MTOR | 0.97059306 |
| 67 | PDPK1 | 0.94240373 |
| 68 | TYK2 | 0.91989440 |
| 69 | TNK2 | 0.91734947 |
| 70 | LMTK2 | 0.91113467 |
| 71 | ITK | 0.90749392 |
| 72 | JAK2 | 0.90502643 |
| 73 | HCK | 0.89675585 |
| 74 | PIM2 | 0.89016796 |
| 75 | LCK | 0.87710456 |
| 76 | CDC42BPA | 0.84774155 |
| 77 | SYK | 0.84693679 |
| 78 | FLT3 | 0.84609902 |
| 79 | MAP3K10 | 0.84504094 |
| 80 | RET | 0.82098003 |
| 81 | ARAF | 0.81110994 |
| 82 | SRPK1 | 0.80938121 |
| 83 | STK10 | 0.80574494 |
| 84 | INSRR | 0.80400712 |
| 85 | SGK2 | 0.80059323 |
| 86 | TRIB3 | 0.79613026 |
| 87 | SIK2 | 0.77442477 |
| 88 | BLK | 0.77352624 |
| 89 | RPS6KA2 | 0.76285204 |
| 90 | EIF2AK2 | 0.74944575 |
| 91 | PIK3CG | 0.74082139 |
| 92 | LYN | 0.73973654 |
| 93 | MAP2K2 | 0.73538668 |
| 94 | MST1R | 0.69849443 |
| 95 | LRRK2 | 0.67390442 |
| 96 | PRKD3 | 0.66663466 |
| 97 | PTK2 | 0.64918322 |
| 98 | PDK1 | 0.62246635 |
| 99 | EPHB1 | 0.61589855 |
| 100 | DDR2 | 0.61527310 |
| 101 | GRK7 | 0.59892669 |
| 102 | CDK6 | 0.58877751 |
| 103 | BMX | 0.58778982 |
| 104 | RPS6KL1 | 0.58523976 |
| 105 | RPS6KC1 | 0.58523976 |
| 106 | NTRK1 | 0.56797711 |
| 107 | MAPK12 | 0.56568745 |
| 108 | RIPK4 | 0.55854862 |
| 109 | RAF1 | 0.55317805 |
| 110 | SGK3 | 0.55069336 |
| 111 | * PRKD2 | 0.54773542 |
| 112 | RPS6KA6 | 0.53482485 |
| 113 | CSF1R | 0.52694663 |
| 114 | TESK2 | 0.50890060 |
| 115 | MAPKAPK2 | 0.50506474 |
| 116 | PRKG2 | 0.50254948 |
| 117 | CHUK | 0.49621743 |
| 118 | ERN1 | 0.49361185 |
| 119 | PRPF4B | 0.47912956 |
| 120 | CAMKK2 | 0.47793988 |
| 121 | NEK6 | 0.47792446 |
| 122 | MAPKAPK3 | 0.47735849 |
| 123 | MAP3K7 | 0.47014314 |
| 124 | ABL1 | 0.46527193 |
| 125 | CAMKK1 | 0.44431374 |
| 126 | CSNK1G1 | 0.43462963 |
| 127 | VRK1 | 0.43162124 |
| 128 | SIK1 | 0.42557994 |
| 129 | MAP3K8 | 0.41983652 |
| 130 | PAK6 | 0.41286337 |
| 131 | MAPK7 | 0.41121396 |
| 132 | CDK9 | 0.39507149 |
| 133 | BCKDK | 0.38163593 |
| 134 | * PRKD1 | 0.37344792 |
| 135 | RPS6KB2 | 0.37288554 |
| 136 | MAP2K1 | 0.37161826 |
| 137 | MAP3K2 | 0.37161033 |
| 138 | MAPK11 | 0.36808508 |
| 139 | PDGFRB | 0.36753551 |
| 140 | MAP3K5 | 0.36160171 |
| 141 | MAP3K1 | 0.35007491 |
| 142 | MAP2K3 | 0.34716295 |
| 143 | PRKCH | 0.34577609 |
| 144 | MAP3K13 | 0.32826932 |
| 145 | FRK | 0.30556875 |
| 146 | BMPR2 | 0.29633671 |
| 147 | PTK6 | 0.28525314 |
| 148 | CDK4 | 0.28292413 |
| 149 | MAPK4 | 0.27874950 |
| 150 | RPS6KA4 | 0.27758583 |
| 151 | MKNK1 | 0.26439563 |
| 152 | CAMK4 | 0.24632303 |
| 153 | CAMK2B | 0.23839963 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Thyroid cancer_Homo sapiens_hsa05216 | 3.01573147 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.98917405 |
| 3 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.90410343 |
| 4 | Measles_Homo sapiens_hsa05162 | 2.55234068 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.46453378 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.43614333 |
| 7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.43579480 |
| 8 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.37895979 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.25885411 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 2.20072287 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.15562908 |
| 12 | Ribosome_Homo sapiens_hsa03010 | 1.98610093 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.83695003 |
| 14 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.78243834 |
| 15 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.76802665 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.72773392 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.66756700 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.65870957 |
| 19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.61100208 |
| 20 | Protein export_Homo sapiens_hsa03060 | 1.57215648 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.56979723 |
| 22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.53347495 |
| 23 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.53165575 |
| 24 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.52206387 |
| 25 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.49438930 |
| 26 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.48756456 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.46844630 |
| 28 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.38773964 |
| 29 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.38426736 |
| 30 | Bladder cancer_Homo sapiens_hsa05219 | 1.31331511 |
| 31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.30688705 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.30652564 |
| 33 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.29660710 |
| 34 | Endometrial cancer_Homo sapiens_hsa05213 | 1.29600654 |
| 35 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.28257710 |
| 36 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.26947958 |
| 37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.26769236 |
| 38 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.23023514 |
| 39 | Prostate cancer_Homo sapiens_hsa05215 | 1.23016024 |
| 40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.22576562 |
| 41 | Sulfur relay system_Homo sapiens_hsa04122 | 1.20524186 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.19744837 |
| 43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.19349482 |
| 44 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.19059596 |
| 45 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.18609838 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.17947831 |
| 47 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.16776703 |
| 48 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.14109094 |
| 49 | Influenza A_Homo sapiens_hsa05164 | 1.12755131 |
| 50 | Glioma_Homo sapiens_hsa05214 | 1.12014345 |
| 51 | Colorectal cancer_Homo sapiens_hsa05210 | 1.08857111 |
| 52 | Allograft rejection_Homo sapiens_hsa05330 | 1.08690875 |
| 53 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.08357070 |
| 54 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.08218224 |
| 55 | Endocytosis_Homo sapiens_hsa04144 | 1.07630248 |
| 56 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.07577156 |
| 57 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.06816294 |
| 58 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.06743265 |
| 59 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.06529124 |
| 60 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.06130524 |
| 61 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.05535578 |
| 62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05409676 |
| 63 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.03702171 |
| 64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.00610028 |
| 65 | Pertussis_Homo sapiens_hsa05133 | 0.99769589 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.99177584 |
| 67 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.99118135 |
| 68 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.98257725 |
| 69 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.97628038 |
| 70 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.95785266 |
| 71 | Lysosome_Homo sapiens_hsa04142 | 0.94227732 |
| 72 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.91492763 |
| 73 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.90803803 |
| 74 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.89467952 |
| 75 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.89133543 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.89060599 |
| 77 | Legionellosis_Homo sapiens_hsa05134 | 0.88299391 |
| 78 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.87605473 |
| 79 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.85936200 |
| 80 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.85691159 |
| 81 | Tuberculosis_Homo sapiens_hsa05152 | 0.84456693 |
| 82 | * Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.84096791 |
| 83 | Hepatitis B_Homo sapiens_hsa05161 | 0.83897457 |
| 84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.83399533 |
| 85 | Focal adhesion_Homo sapiens_hsa04510 | 0.83101869 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.82808955 |
| 87 | Amoebiasis_Homo sapiens_hsa05146 | 0.82520204 |
| 88 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.80611276 |
| 89 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.79762413 |
| 90 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.79373253 |
| 91 | Malaria_Homo sapiens_hsa05144 | 0.77906941 |
| 92 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.77345888 |
| 93 | HTLV-I infection_Homo sapiens_hsa05166 | 0.76875082 |
| 94 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.76683600 |
| 95 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.75802158 |
| 96 | Apoptosis_Homo sapiens_hsa04210 | 0.74642649 |
| 97 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.74371725 |
| 98 | Phagosome_Homo sapiens_hsa04145 | 0.71967814 |
| 99 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.71904663 |
| 100 | ABC transporters_Homo sapiens_hsa02010 | 0.71679351 |
| 101 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.71223749 |
| 102 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.70861362 |
| 103 | DNA replication_Homo sapiens_hsa03030 | 0.70728957 |
| 104 | Platelet activation_Homo sapiens_hsa04611 | 0.70555866 |
| 105 | Adherens junction_Homo sapiens_hsa04520 | 0.70527531 |
| 106 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.70021299 |
| 107 | Hepatitis C_Homo sapiens_hsa05160 | 0.67330921 |
| 108 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.67320597 |
| 109 | Galactose metabolism_Homo sapiens_hsa00052 | 0.66995543 |
| 110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66638966 |
| 111 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.66496691 |
| 112 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.66231967 |
| 113 | Prion diseases_Homo sapiens_hsa05020 | 0.63997350 |
| 114 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63858490 |
| 115 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61953675 |
| 116 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.59956598 |
| 117 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.58248522 |
| 118 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57736954 |
| 119 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56775129 |
| 120 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.56439703 |
| 121 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.56106855 |
| 122 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.55575106 |
| 123 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.54608454 |
| 124 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54199481 |
| 125 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.53381720 |
| 126 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.53262779 |
| 127 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.52697419 |
| 128 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.50552922 |
| 129 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48781697 |
| 130 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.47582469 |
| 131 | Retinol metabolism_Homo sapiens_hsa00830 | 0.46409665 |
| 132 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.45261135 |
| 133 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45210860 |
| 134 | Spliceosome_Homo sapiens_hsa03040 | 0.44179049 |
| 135 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.43050506 |
| 136 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.42810422 |
| 137 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.41291353 |
| 138 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.40792657 |
| 139 | Lysine degradation_Homo sapiens_hsa00310 | 0.40641707 |
| 140 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.38133723 |
| 141 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.38033358 |
| 142 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.37765314 |
| 143 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.37151781 |
| 144 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.36199127 |
| 145 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35813054 |
| 146 | Viral myocarditis_Homo sapiens_hsa05416 | 0.33662402 |
| 147 | Salmonella infection_Homo sapiens_hsa05132 | 0.32604833 |
| 148 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.31212959 |
| 149 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.30184795 |
| 150 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.30074673 |

